Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
---|
11/21/2002 | WO2002072878A3 Method for forgery-proof marking; forgery-proof marking and kit |
11/21/2002 | WO2002069896A3 Connexin enhances chemotherapy-induced apoptosis in human cancer cells inhibiting tumor cell proliferation |
11/21/2002 | WO2002068933A3 Small molecule design against drug resistant mutants using directed evolution |
11/21/2002 | WO2002063308A3 Prediction of wound healing by urinary nitrate assay |
11/21/2002 | WO2002062824A3 Method of treating amyloid ? precursor disorder |
11/21/2002 | WO2002062464A3 Active member of a chemical library |
11/21/2002 | WO2002060340A9 Method for identifying maxi-k channel blockers |
11/21/2002 | WO2002059604A8 Diagnosis and treatment of multiple sclerosis |
11/21/2002 | WO2002058532A3 Method for identifying ligands to lxr-receptor that stimulates pre-adipocyte differentiation and formulations thereof |
11/21/2002 | WO2002057779A9 Cloning and expression of a new mcp receptor in glial cells |
11/21/2002 | WO2002055720A3 Materials and methods relating to protein aggregation in neurodegenerative disease |
11/21/2002 | WO2002055089B1 Immunoassay technique using multispecific molecules |
11/21/2002 | WO2002052014A3 Efficient expression of plasmodium apical membrane antigen 1 in yeast cells |
11/21/2002 | WO2002046748A3 Compact sensor using microcavity structures |
11/21/2002 | WO2002046381A3 Method for the prevention or reduction of haze in beverages |
11/21/2002 | WO2002043765A3 Pharmaceutical formulations comprising paclitaxel, derivatives, and pharmaceutically acceptable salts thereof |
11/21/2002 | WO2002037106A3 Methods for comparitive analysis of carbohydrate polymers |
11/21/2002 | WO2002031201A3 Mammalian two-hybrid system for screening for modulators of the accumulation of metabolic products |
11/21/2002 | WO2002029503A8 Flexible protocol generator |
11/21/2002 | WO2002028841B1 Reagents for labeling biomolecules having aldehyde or ketone moieties |
11/21/2002 | WO2002025630A3 Microfabricated ultrasound array for use as resonant sensors |
11/21/2002 | WO2002018637A3 Diagnosis and treatment of prostate cancer |
11/21/2002 | WO2002017362A8 Doped elongated semiconductors, growing such semiconductors, devices including such semiconductors and fabricating such devices |
11/21/2002 | WO2002014467A3 Cng2b: a putative human cyclic nucleotide-gated ion channel |
11/21/2002 | WO2002004957A3 Fourier transform mass spectrometry of complex biological samples |
11/21/2002 | WO2002000926A3 Diagnosis of diseases associated with signal transduction |
11/21/2002 | WO2002000730A3 Pd-l2 molecules: novel pd-1 ligands and uses therefor |
11/21/2002 | WO2001094935A3 Labeling of proteomic samples during proteolysis for quantitation and sample multiplexing |
11/21/2002 | WO2001080876A8 Utilization of adamts-1 protein and method of screening aggrecanase activity regulator |
11/21/2002 | WO2001042273A9 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
11/21/2002 | WO2001036475A9 Biglycan and related therapeutics and methods of use |
11/21/2002 | WO2001025002A9 Colloidal rod particles as nanobar codes |
11/21/2002 | WO2001023886A9 Improved toxicity screening method |
11/21/2002 | WO2001019397A9 Methods and compositions utilizing rad51 |
11/21/2002 | US20020174446 Identification of genes involved in alzheimer's disease using drosophila melanogaster |
11/21/2002 | US20020174096 Interactive correlation of compound information and genomic information |
11/21/2002 | US20020173915 Method for modelling fluid displacements in a porous environment taking into account hysteresis effects |
11/21/2002 | US20020173706 Oxygen-saturation measuring apparatus |
11/21/2002 | US20020173641 Nucleotide sequences coding polypeptides for use in human therapeutics, pharmacology and diagnostics |
11/21/2002 | US20020173638 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of ovarian cancer |
11/21/2002 | US20020173633 Characterization of phenylalanine ammonia-lyase (PAL) gene in wounded lettuce tissue |
11/21/2002 | US20020173626 Fusion protein for use in the diagnosis, prevention and treatment of liver disorders |
11/21/2002 | US20020173495 Selective androgen receptor modulators and methods of use thereof |
11/21/2002 | US20020173493 Method for measurement of hepatitis C virus |
11/21/2002 | US20020173480 Polynucleotides; analyzing binding between detector and target |
11/21/2002 | US20020173474 Methods & materials involving dimerization-mediated regulation of biological events |
11/21/2002 | US20020173469 Protease inhibitors |
11/21/2002 | US20020173464 Modulation of pericyte proliferation |
11/21/2002 | US20020173463 Isolated nucleic acids; and antibodies |
11/21/2002 | US20020173461 Methods for enhancing the efficacy of cancer therapy |
11/21/2002 | US20020173459 Isolated peptide; antibodies; genetic engineering |
11/21/2002 | US20020173458 Polypeptides; genetic engineering |
11/21/2002 | US20020173457 Polypeptides |
11/21/2002 | US20020173454 Nucleic acids, proteins, and antibodies |
11/21/2002 | US20020173449 O-superfamily conotoxin peptides |
11/21/2002 | US20020173445 Selective androgen receptor modulators and methods for their identification, design and use |
11/21/2002 | US20020173053 Multiple simultaneous antigen detection by immunohistochemistry |
11/21/2002 | US20020173052 Method for performing submicroliter crystallization experiments with high experiment to experiment precision |
11/21/2002 | US20020173050 Prewetting stop flow test strip |
11/21/2002 | US20020173045 Method for determining the size of a spherical or elipsoidal molecule |
11/21/2002 | US20020173044 Methods for determination of glycated haemoglobin |
11/21/2002 | US20020173043 Cyanide-free reagent, and method for detecting hemoglobin |
11/21/2002 | US20020173042 Method of tagging agricultural products |
11/21/2002 | US20020173041 Method and apparatus for obtaining physical and/or chemical characteristics of a biological medium |
11/21/2002 | US20020173040 Apparatus for use in the determining barrier property of coatings |
11/21/2002 | US20020173029 Chemical structure for use in the prevention and treatment of viral infections |
11/21/2002 | US20020173007 Human chemokine polypeptides |
11/21/2002 | US20020172999 Novel KIAA1061-like cell adhesion molecule-like proteins and polynucleotides encoding them |
11/21/2002 | US20020172992 Method for the determination of glycated hemoglobin |
11/21/2002 | US20020172990 Cyclin dependent kinase 5 phosphorylation of disabled 1 protein |
11/21/2002 | US20020172987 Methods and reagents for the rapid and efficient isolation of circulating cancer cells |
11/21/2002 | US20020172983 Diagnosis of pathologies of mononucleated blood cells |
11/21/2002 | US20020172982 Glycoprotein for use in diagnosis and treatment of human sexual disorders |
11/21/2002 | US20020172981 Nucleic acid molecules encoding human kinase and phosphatase homologues and uses therefor |
11/21/2002 | US20020172980 Methods for decreasing non-specific binding of beads in dual bead assays including related optical biodiscs and disc drive systems |
11/21/2002 | US20020172979 Method for identifying cytotoxic T-cell epitopes |
11/21/2002 | US20020172978 Methods and kits for diagnosing or monitoring synovial or osteoarticular disease, comprising the use of a specific marker for synovial tissue degradation |
11/21/2002 | US20020172973 Composite material sheet for analysis of substances originating from living body or analogues thereof |
11/21/2002 | US20020172967 Identification of non-covalent complexes by mass spectrometry |
11/21/2002 | US20020172963 DNA-bridged carbon nanotube arrays |
11/21/2002 | US20020172962 Generation of nucleotide sequence ligands; obtain nucleotide sequences mixture, separate nucleotide sequences, amplify nucleotide sequences, incubate with modulator, detect adjustment in binding activity |
11/21/2002 | US20020172961 Sequencing preferential nucleotide sequences; obtain oligomer, label, digest, separate, perform mass spectrum analysis, determine sequence |
11/21/2002 | US20020172959 Compositions and methods relating to lung specific genes and proteins |
11/21/2002 | US20020172958 Methods of diagnosing, preventing and treating neurological disorders and neuronal injuries |
11/21/2002 | US20020172957 Nucleotide squences coding preferential polypepttide for use in the diagnosis, prevention, treatment and classification of lung cancer |
11/21/2002 | US20020172943 Device and method of use for detection and characterization of pathogens and biological materials |
11/21/2002 | US20020172941 Inducing immune response against feline immunodeficiency virus; obtain animal, administer protective agent, detect immunological response against viral infection |
11/21/2002 | US20020172940 Methods and reagents for isolating biologically active peptides |
11/21/2002 | US20020172939 DNA, RNA, amino acid sequences for detecting antibodies against retroviruses which are associated with immunodeficiency diseases; diagnosis |
11/21/2002 | US20020172937 Rapid assay for arthopod-borne disease vectors and pathogens |
11/21/2002 | US20020172936 Detecting viral disease in humans; obtain tissue, expose to radiation, analyze absorption data, evaluate for disease |
11/21/2002 | US20020172935 Methods of screening for compounds that modulate blood vessel formation from circulating endothelial cell precursors |
11/21/2002 | US20020172826 Nanoscale catalyst compositions from complex and non-stoichiometric compositions |
11/21/2002 | US20020172690 Infectious cDNA clone of north american porcine reproductive and respiratory syndrome (PRRS) virus and uses thereof |
11/21/2002 | US20020172684 Useful in therapy, diagnosis, and prophylaxis of tuberculosis; vaccines |
11/21/2002 | US20020172683 Used for therapy of viral pathologies, such as those due to HIV-1 or HIV-2 infections, for screening compounds |
11/21/2002 | US20020172681 Contacting Th2 cells with vMIP-I or an agonist or antagonist for modulating physiological signal specific to Th2 cells |
11/21/2002 | US20020172679 Treatment of inflammatory bowel disease by inhibiting binding and/or signalling through alpha4beta7 and its ligands and MAdCAM |
11/21/2002 | US20020172678 For regulating cellular proliferation and chemotaxis |
11/21/2002 | US20020172676 Method of treatment of alzheimer's disease and device therefor |